$ADMP I know its not sexy, but the compounding industry is heating up. Pharmedium, QUva, and others are acquiring at a rapid pace. WIth the growth and expansion at USC, this has most certainly become more appealing as a revenue stream and possible acquisition. Hosppitals can no longer mix syringes and use as they once did (especially for OR and anesthesia) . Certain laws (USP 797) have forced them to outsource a lot of these highly used drugs that need diluted. Dont turn a blind eye and poo poo this revenue stream. It could be crucial.
  • 3
  • 3